ABUS ARBUTUS BIOPHARMA CORP US FDA Inspections 8-K Filing 2023 - Other Events Arbutus Biopharma Corp announced that their AB-101 Investigational New Drug application has been placed on clinical hold by the FDA.Get access to all SEC 8-K filings of the ARBUTUS BIOPHARMA CORP